Invention Grant
- Patent Title: FGL2 antibodies and binding fragments thereof and uses thereof
-
Application No.: US16642685Application Date: 2018-05-03
-
Publication No.: US11325969B2Publication Date: 2022-05-10
- Inventor: Gary Levy , Ramzi Khattar , Andrzej Chruscinski , Barbara Vanderhyden , Curtis McCloskey
- Applicant: Veritas Therapeutics Inc.
- Applicant Address: CA Thornhill
- Assignee: Veritas Therapeutics Inc.
- Current Assignee: Veritas Therapeutics Inc.
- Current Assignee Address: CA Thornhill
- Agency: Bereskin & Parr LLP/S.E.N.C.R.L., s.r.l.
- Agent Ainslie Parsons
- International Application: PCT/CA2018/050527 WO 20180503
- International Announcement: WO2019/041024 WO 20190307
- Main IPC: C07K16/18
- IPC: C07K16/18 ; G01N33/574 ; A61K39/00 ; A61P35/00
Abstract:
The disclosure is directed to antibodies and binding fragments thereof that specifically bind FGL2. The disclosure is also directed to uses of the antibodies and binding fragments thereof for treating cancer.
Information query
